Baird Financial Group, Inc. Exact Sciences Corp Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 326,935 shares of EXAS stock, worth $18.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

326,935

Previous 283,374 15.37%

Holding current value

$18.8 Million

Previous $12 Million 85.94%

% of portfolio

0.04%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$42.43 - $70.83 $1.85 Million - $3.09 Million	43,561 Added 15.37%	326,935 $22.3 Million
Q2 2024 Aug 13, 2024	SELL	$41.33 - $74.26 $558,078 - $1 Million	-13,503 Reduced 4.55%	283,374 $12 Million
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $2.03 Million - $2.66 Million	-36,023 Reduced 10.82%	296,877 $20.5 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $5.61 Million - $7.2 Million	95,062 Added 39.97%	332,900 $24.6 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $48,993 - $73,586	743 Added 0.31%	237,838 $16.2 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $1.01 Million - $1.54 Million	16,191 Added 7.33%	237,095 $22.3 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $1.17 Million - $1.76 Million	24,804 Added 12.65%	220,904 $15 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $848,547 - $1.31 Million	26,542 Added 14.52%	209,375 $6.8 Million
Q2 2022 Aug 08, 2022	SELL	$35.61 - $76.23 $153,657 - $328,932	-4,315 Reduced 2.31%	182,833 $7.2 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $168,881 - $242,172	2,934 Added 1.59%	187,148 $13.1 Million
Q4 2021 Feb 09, 2022	SELL	$72.5 - $100.68 $756,827 - $1.05 Million	-10,439 Reduced 5.36%	184,214 $14.3 Million
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $360,960 - $496,200	4,000 Added 2.1%	194,653 $18.6 Million
Q2 2021 Aug 11, 2021	SELL	$93.66 - $139.27 $15,079 - $22,422	-161 Reduced 0.08%	190,653 $23.7 Million
Q1 2021 May 13, 2021	SELL	$116.57 - $155.01 $1.85 Million - $2.46 Million	-15,867 Reduced 7.68%	190,814 $25.1 Million
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $1.06 Million - $1.52 Million	-10,678 Reduced 4.91%	206,681 $27.4 Million
Q3 2020 Nov 12, 2020	SELL	$72.92 - $102.01 $587,589 - $821,996	-8,058 Reduced 3.57%	217,359 $22.2 Million
Q2 2020 Oct 22, 2020	BUY	$55.75 - $92.75 $1.28 Million - $2.14 Million	23,027 Added 11.38%	225,417 $19.6 Million
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $688,512 - $1.15 Million	-12,350 Reduced 5.75%	202,390 $18.7 Million
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $759,440 - $2.09 Million	20,038 Added 10.29%	214,740 $12.5 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $436,060 - $560,040	-5,615 Reduced 2.8%	194,702 $18 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $287,647 - $389,885	-3,183 Reduced 1.56%	200,317 $18.1 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $48,872 - $64,449	-546 Reduced 0.27%	203,500 $24 Million
Q1 2019 May 14, 2019	BUY	$61.98 - $96.5 $2.46 Million - $3.84 Million	39,770 Added 24.21%	204,046 $17.7 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $2.86 Million - $4.22 Million	-51,014 Reduced 23.7%	164,276 $10.4 Million
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $2,511 - $4,191	52 Added 0.02%	215,290 $17.1 Million
Q2 2018 Aug 13, 2018	BUY	$37.84 - $69.96 $254,057 - $469,711	6,714 Added 3.22%	215,238 $12.9 Million
Q1 2018 May 14, 2018	SELL	$39.82 - $57.53 $207,661 - $300,018	-5,215 Reduced 2.44%	208,524 $8.41 Million
Q4 2017 Feb 09, 2018	SELL	$46.49 - $60.51 $1.17 Million - $1.52 Million	-25,163 Reduced 10.53%	213,739 $11.2 Million
Q3 2017 Nov 14, 2017	SELL	$37.05 - $47.12 $33,789 - $42,973	-912 Reduced 0.38%	238,902 $11.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	239,814	239,814 $8.48 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Exact Sciences Corp Transaction History